Unknown

Dataset Information

0

Site-specific protein transamination using N-methylpyridinium-4-carboxaldehyde.


ABSTRACT: The controlled attachment of synthetic groups to proteins is important for a number of fields, including therapeutics, where antibody-drug conjugates are an emerging area of biologic medicines. We have previously reported a site-specific protein modification method using a transamination reaction that chemoselectively oxidizes the N-terminal amine of a polypeptide chain to a ketone or an aldehyde group. The newly introduced carbonyl can be used for conjugation to a synthetic group in one location through the formation of an oxime or a hydrazone linkage. To expand the scope of this reaction, we have used a combinatorial peptide library screening platform as a method to explore new transamination reagents while simultaneously identifying their optimal N-terminal sequences. N-Methylpyridinium-4-carboxaldehyde benzenesulfonate salt (Rapoport's salt, RS) was identified as a highly effective transamination reagent when paired with glutamate-terminal peptides and proteins. This finding establishes RS as a transamination reagent that is particularly well suited for antibody modification. Using a known therapeutic antibody, herceptin, it was demonstrated that RS can be used to modify the heavy chains of the wild-type antibody or to modify both the heavy and the light chains after N-terminal sequence mutation to add additional glutamate residues.

SUBMITTER: Witus LS 

PROVIDER: S-EPMC4136391 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Site-specific protein transamination using N-methylpyridinium-4-carboxaldehyde.

Witus Leah S LS   Netirojjanakul Chawita C   Palla Kanwal S KS   Muehl Ellen M EM   Weng Chih-Hisang CH   Iavarone Anthony T AT   Francis Matthew B MB  

Journal of the American Chemical Society 20131105 45


The controlled attachment of synthetic groups to proteins is important for a number of fields, including therapeutics, where antibody-drug conjugates are an emerging area of biologic medicines. We have previously reported a site-specific protein modification method using a transamination reaction that chemoselectively oxidizes the N-terminal amine of a polypeptide chain to a ketone or an aldehyde group. The newly introduced carbonyl can be used for conjugation to a synthetic group in one locatio  ...[more]

Similar Datasets

| S-EPMC4769283 | biostudies-literature
| S-EPMC5201207 | biostudies-literature
| S-EPMC6389862 | biostudies-literature
| S-EPMC4892701 | biostudies-literature
| S-EPMC2855580 | biostudies-literature
2022-04-25 | GSE200262 | GEO
| S-EPMC4758125 | biostudies-literature
| S-EPMC7012368 | biostudies-literature
| S-EPMC4120581 | biostudies-literature
| S-EPMC6669078 | biostudies-literature